|Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas|
C Palles, JB Cazier, KM Howarth, E Domingo, AM Jones, P Broderick, ...
Nature genetics 45 (2), 136-144, 2013
|Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk|
AL Sherborne, FJ Hosking, RB Prasad, R Kumar, R Koehler, ...
Nature genetics 42 (6), 492-494, 2010
|Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients|
V Shah, AL Sherborne, BA Walker, DC Johnson, EM Boyle, S Ellis, ...
Leukemia 32 (1), 102-110, 2018
|The genetic basis of inbreeding avoidance in house mice|
AL Sherborne, MD Thom, S Paterson, F Jury, WER Ollier, P Stockley, ...
Current biology 17 (23), 2061-2066, 2007
|Variation at 10p12. 2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype|
G Migliorini, B Fiege, FJ Hosking, Y Ma, R Kumar, AL Sherborne, ...
Blood, The Journal of the American Society of Hematology 122 (19), 3298-3307, 2013
|Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer|
D Chubb, P Broderick, SE Dobbins, M Frampton, B Kinnersley, S Penegar, ...
Nature communications 7 (1), 11883, 2016
|Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing|
D Chubb, P Broderick, M Frampton, B Kinnersley, A Sherborne, ...
Journal of Clinical Oncology 33 (5), 426-432, 2015
|Baculum morphology predicts reproductive success of male house mice under sexual selection|
P Stockley, SA Ramm, AL Sherborne, MDF Thom, S Paterson, JL Hurst
BMC biology 11 (1), 1-6, 2013
|Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated …|
JR Jones, N Weinhold, C Ashby, BA Walker, C Wardell, C Pawlyn, ...
Haematologica 104 (7), 1440, 2019
|Developmental timing of mutations revealed by whole-genome sequencing of twins with acute lymphoblastic leukemia|
Y Ma, SE Dobbins, AL Sherborne, D Chubb, M Galbiati, G Cazzaniga, ...
Proceedings of the National Academy of Sciences 110 (18), 7429-7433, 2013
|Role of 657del5 NBN mutation and 7p12. 2 (IKZF1), 9p21 (CDKN2A), 10q21. 2 (ARID5B) and 14q11. 2 (CEBPE) variation and risk of childhood ALL in the Polish population|
A Pastorczak, P Górniak, A Sherborne, F Hosking, J Trelińska, M Lejman, ...
Leukemia research 35 (11), 1534-1536, 2011
|The silent mutational landscape of infant MLL‐AF4 pro‐B acute lymphoblastic leukemia|
SE Dobbins, AL Sherborne, YP Ma, M Bardini, A Biondi, G Cazzaniga, ...
Genes, Chromosomes and Cancer 52 (10), 954-960, 2013
|Variation at 7p12. 2 and 10q21. 2 influences childhood acute lymphoblastic leukemia risk in the Thai population and may contribute to racial differences in leukemia incidence|
J Vijayakrishnan, AL Sherborne, R Sawangpanich, S Hongeng, ...
Leukemia & lymphoma 51 (10), 1870-1874, 2010
|Rationale for an international consortium to study inherited genetic susceptibility to childhood acute lymphoblastic leukemia|
AL Sherborne, K Hemminki, R Kumar, CR Bartram, M Stanulla, ...
Haematologica 96 (7), 1049, 2011
|Multiple Hodgkin lymphoma–associated loci within the HLA region at chromosome 6p21. 3|
L Moutsianas, V Enciso-Mora, YP Ma, S Leslie, A Dilthey, P Broderick, ...
Blood, The Journal of the American Society of Hematology 118 (3), 670-674, 2011
|Mutational analysis of ionizing radiation induced neoplasms|
AL Sherborne, PR Davidson, K Yu, AO Nakamura, M Rashid, ...
Cell reports 12 (11), 1915-1926, 2015
|Subclonal TP53 copy number is associated with prognosis in multiple myeloma|
V Shah, DC Johnson, AL Sherborne, S Ellis, FM Aldridge, ...
Blood, The Journal of the American Society of Hematology 132 (23), 2465-2469, 2018
|Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients|
V Shah, AL Sherborne, DC Johnson, S Ellis, A Price, F Chowdhury, ...
Leukemia 34 (11), 3091-3096, 2020
|Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors|
AL Sherborne, V Lavergne, K Yu, L Lee, PR Davidson, T Mazor, ...
Clinical Cancer Research 23 (7), 1852-1861, 2017
|Copy number evolution and its relationship with patient outcome—an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial|
J Croft, S Ellis, AL Sherborne, K Sharp, A Price, MW Jenner, MT Drayson, ...
Leukemia 35 (7), 2043-2053, 2021